Navigation Links
Catalent Expert to Present on Enhancing Bioavailability of Poorly Absorbed Drugs at Japan Society of Drug Delivery Systems
Date:7/29/2014

Somerset, NJ (PRWEB) July 29, 2014

Catalent Pharma Solutions, the global leader in drug development solutions and advanced delivery technologies for pharmaceutical, biologic, and consumer health products, today announced that Dr. Jeff Browne, R&D Director and US Platform Leader of Pharmaceutical Softgels, will present “Enhancing the Bioavailability of Absorption-Limited Drugs with Lipid-Based Formulations using Soft Capsule Delivery Systems” at the forthcoming 30th Annual Meeting of the Japan Society of Drug Delivery Systems (30-31 July 2014, Tokyo, Japan).

Dr. Browne’s presentation, which is a luncheon seminar on Wednesday July 30th, at 12.00 noon, will provide insight into the usefulness of lipid-based formulations to enhance absorption for drugs with limited oral bioavailability, characterized by poor solubility and/or permeability. The process of preformulation studies and prototype formulation development on a placebo lipid-based formulation will be used to demonstrate the considerations necessary before highlighting the benefits of soft capsules as a delivery method for such formulations. Catalent’s non-gelatin OptiShell™ capsule technology has successfully been used to overcome incompatibilities with gelatin-based shells, and more recently, the use of film-coated soft capsules has been investigated.

Dr. Browne’s career with Catalent started in 1994 and since then, he has held a number of positions before becoming R&D Director and US Platform Leader of Pharma Softgels. These included Executive Director & Division Head of Pharmaceutical Development in Research Triangle Park, NC, and most recently Technical Director, Pharmaceutical Softgels. He is an active member of the American Association of Pharmaceutical Scientists (AAPS) and has served on several of their Focus Group committees. He is a frequent presenter at both regional and national AAPS meetings. Dr. Browne received his Ph.D. from Purdue University in Industrial and Physical Pharmacy.

For more information on the Japan Society of Drug Delivery Systems, visit: http://www.procomu.jp/DDS2014/index.html, and to arrange a meeting with Dr. Browne, contact Richard Kerns at richard(at)nepr(dot)eu.

About Catalent:

Catalent Pharma Solutions is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance, and ensuring reliable clinical and commercial product supply. Catalent employs approximately 8,500 people, including over 1,000 scientists, at nearly 30 facilities across 5 continents, and in Fiscal 2013, generated more than $1.8 billion in annual revenue. Catalent is headquartered in Somerset, N.J. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Read the full story at http://www.prweb.com/releases/2014/07/prweb12054220.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Pure MHC and Catalent Sign RL21 Anti-Cancer Development Deal
2. Catalent’s Clinical Trial Supply Facility in Shanghai, China Opens for Business
3. Catalent Creates New Advanced Delivery Technologies Business Unit
4. Oxnard Dental Implant Experts Warn of Infections Around Dental Implants
5. Lift U.S. Ban on Blood Donations by Gay Men, Experts Say
6. Fitness Marketing Expert Bedros Keuilian’s New Post Shares Why People Still Need Personal Trainers in the Age of Google
7. Mindy Berkson, Infertility Expert and Founder, Lotus Blossom Consulting LLC: Leading the Pathway to Parenthood
8. New Video Release: Jason Feruggia’s Interview with Personal Trainer Marketing Expert Bedros Keuilian
9. Psoriatic arthritis patients need better screening, warns panel of experts
10. Willem de Liefde, Author and Management Expert, Releases New Guide for Understanding Friends, Family, Co-Workers and Ourselves
11. PoisonEXPERT™ from ExPub Now Available
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Los Angeles, CA (PRWEB) , ... February 08, 2016 , ... ... autism conference held annually in this country. The AutismOne 2016 Conference, which is being ... the truth they often won’t hear elsewhere about helpful interventions and causes of chronic ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... MyDecision™ empowers employers and organizations with the tools and information to lower the ... elements to cut the cost of providing employee healthcare benefits by as much ...
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX LUT: Summer ... grades to their footage. A LUT is a Lookup Table that contains a mathematical ... color indicated by the table. By manipulating each pixel, LUT's can change each color ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air at King Kullen! ... assortments and packaging. This staple for Valentine’s Day is a must-have, and can be ... Valentine’s Day, not only are long-stem roses available, but also other flower bouquets, elegantly ...
(Date:2/5/2016)... ... 2016 , ... The event is being held on April 7, 2016 from ... Triumph Over Parkinson’s will fund nearly $100,000 for research for the care and cure ... disease and is the architect of this informative event to raise awareness and funds ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... , Feb. 4, 2016 Summary Breast ... cancer and the most common cancer in women worldwide, ... disease exceedingly prevalent. The number of women diagnosed with ... but the number of deaths has declined due to ... treatment has been revolutionized in the past four decades, ...
(Date:2/4/2016)... VIEW, Calif., Feb. 4, 2016  Omnicell, Inc. (NASDAQ: ... management solutions to healthcare systems, today announced results for ... --> --> GAAP ... $130.3 million, up $5.1 million or 4.1% from the ... 7.2% from the fourth quarter of 2014. Revenue for ...
(Date:2/4/2016)... 4, 2016 In response to the opioid abuse ... Commissioner for Medical Products and Tobacco, along with other FDA ... agency,s approach to opioid medications. The plan will focus on ... in pain access to effective relief. ... , Re-examine the risk-benefit paradigm for opioids and ensure that ...
Breaking Medicine Technology: